Investors Purchase Large Volume of Call Options on Cronos Group (NASDAQ:CRON)

Cronos Group Inc. (NASDAQ:CRON) was the target of some unusual options trading activity on Friday. Stock investors acquired 10,740 call options on the stock. This represents an increase of 63% compared to the average volume of 6,596 call options.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Bank of America lifted their target price on shares of Cronos Group from $2.00 to $2.50 and gave the company an “underperform” rating in a research report on Monday, April 8th. CIBC lifted their target price on shares of Cronos Group from $3.00 to $3.50 and gave the company an “outperformer” rating in a research report on Wednesday.

Hedge Funds Weigh In On Cronos Group

Several institutional investors have recently added to or reduced their stakes in the company. Chesapeake Capital Corp IL bought a new position in shares of Cronos Group in the fourth quarter worth about $25,000. Toronto Dominion Bank raised its stake in shares of Cronos Group by 204.8% in the first quarter. Toronto Dominion Bank now owns 17,054 shares of the company’s stock worth $45,000 after acquiring an additional 11,459 shares during the last quarter. Revisor Wealth Management LLC bought a new position in shares of Cronos Group in the first quarter worth about $51,000. Cedar Wealth Management LLC bought a new position in shares of Cronos Group in the first quarter worth about $60,000. Finally, Concurrent Investment Advisors LLC bought a new position in shares of Cronos Group in the first quarter worth about $79,000. 8.71% of the stock is owned by institutional investors.

Cronos Group Stock Down 4.0 %

Shares of CRON stock opened at $2.90 on Friday. Cronos Group has a 12-month low of $1.64 and a 12-month high of $3.14. The company has a market capitalization of $1.11 billion, a P/E ratio of -19.33 and a beta of 1.11. The firm has a 50-day moving average price of $2.54 and a 200 day moving average price of $2.21.

Cronos Group (NASDAQ:CRON) last announced its quarterly earnings results on Thursday, May 9th. The company reported ($0.01) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.01). Cronos Group had a negative net margin of 61.31% and a negative return on equity of 3.06%. The firm had revenue of $25.29 million during the quarter, compared to the consensus estimate of $24.30 million. During the same period last year, the firm posted ($0.03) EPS.

About Cronos Group

Cronos Group Inc operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands.